Dr. Glenn J. Smits
Senior Vice President, Discovery and Early Development
Dr. Smits joined vivoPharm in 2013 as Director of Business Development and Marketing and became Vice President of Pharmacology and Toxicology in 2015. Upon the acquisition of vivoPharm by Cancer Genetics Inc, Dr. Smits was promoted to the role of Senior Vice President, Discovery and Early Development. He was previously Vice President and General Manager of the Discovery Sciences division of MPI Research, where he was responsible for the strategic direction, growth, and performance of the division, consisting of the departments of Drug Metabolism/Pharmacokinetics, Experimental Therapeutics, Surgical Services, Molecular and Cellular Biology, and Molecular Imaging. As Scientific Director of the Interventional and Surgical Services business unit at Charles River Laboratories, Glenn directed the execution and quality of the scientific research within the unit. In addition to his extensive experience in the CRO industry, he has spent over 15 years in biopharmaceutical R&D, holding various senior management and scientific management positions at Genome Therapeutics, Biogen, Rhone-Poulenc Rorer (now part of Sanofi-Aventis), and Searle R&D (now part of Pfizer). Dr. Smits has a BS in Biology from Marquette University, a MS in Pharmacology from the Medical College of Wisconsin, and a PhD in Pharmacology from St. Louis University School of Medicine.